Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID06322680

Impact of External Versus Internal Drainage of Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula After Pancreaticoduodenectomy: A Prospective Randomized Controlled Trial

Led by Shanghai Zhongshan Hospital · Updated on 2025-01-22

322

Participants Needed

1

Research Sites

140 weeks

Total Duration

On this page

Sponsors

S

Shanghai Zhongshan Hospital

Lead Sponsor

H

Huadong Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating the impact of external drainage of the main pancreatic duct and common bile duct on postoperative complications, especially pancreatic fistula, following pancreaticoduodenectomy (PD). PD is the standard surgery for tumors in the pancreatic head, distal bile duct, duodenum, and ampulla of Vater. Advances have lowered mortality rates to under 5% in specialized centers, but postoperative complication rates remain high, especially pancreatic fistula, which can cause serious infections and death. Current treatments to prevent fistula include pancreatic duct stent external drainage and biliary drainage, but their effectiveness is unclear, particularly in patients with varying risk levels of pancreatic fistula. The study compares two approaches: external drainage and internal drainage of the pancreatic and biliary ducts during PD surgery. External drainage involves placing drainage tubes with one-way valves to divert pancreatic and biliary juices outside the body. Internal drainage includes creating a connection (anastomosis) between the ducts and the jejunum without external tubes. Both procedures involve carefully assessing pancreatic texture and duct diameter and use different surgical techniques to connect the pancreas and bile duct to the intestines. Participants will be monitored for 90 days after surgery to track the occurrence of clinically relevant pancreatic fistula and other complications. Researchers will evaluate postoperative outcomes, including fistula rates, and safety measures. Study visits will include clinical assessments, imaging, and laboratory tests to monitor recovery and complications. The goal is to better understand whether external drainage reduces pancreatic fistula risk in patients with intermediate or high risk as determined by a specific scoring system, helping improve treatment after PD surgery.

CONDITIONS

Official Title

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent before treatment
  • Age 18 years or older and 80 years or younger
  • ECOG performance status of 0 or 1, life expectancy of 12 weeks or more, and ASA score 2 or less
  • Clinical diagnosis indicating need for pancreaticoduodenectomy for tumors of the pancreatic head, ampulla of Vater, duodenum, or distal common bile duct
  • No serious dysfunction of blood, heart, lung, or autoimmune systems
  • White blood cell count at least 3 x 10^9/L; absolute neutrophil count at least 1.5 x 10^9/L; platelets at least 100 x 10^9/L; hemoglobin at least 90 g/L
  • Liver enzymes (AST/ALT) no more than 2.5 times the upper normal limit; total bilirubin within normal limits; creatinine no more than 1.5 times upper normal limit
  • Prothrombin time and INR no more than 1.5 times upper normal limit
  • Able to follow study visit plans and protocol requirements
  • Intermediate or high risk of postoperative pancreatic fistula according to alternative fistula risk scoring system (A-FRS)
Not Eligible

You will not qualify if you...

  • Late-stage cancer with distant organ metastasis or extensive lymph node involvement
  • Tumor invasion of major arteries or veins including superior mesenteric artery, celiac trunk, inferior vena cava, or abdominal aorta
  • Congestive heart failure with NYHA class 3 or 4
  • Uncontrolled hypertension
  • Renal failure requiring dialysis
  • Serious active infection greater than Grade 2
  • Pregnancy or breastfeeding
  • Major surgery within 4 weeks before starting the trial or not recovered from it
  • Other malignant tumors unless cured for more than 3 years
  • Recent upper gastrointestinal bleeding within 4 weeks or ongoing bleeding risk
  • Poor compliance or unwillingness to sign informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongshan Hospital

Shanghai, Shanghai Municipality, China, 200000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trial.

Wen-Quan Wang, Yao-Lin Xu, Lin-Hui Tang...

https://pubmed.ncbi.nlm.nih.gov/41189489